Company / FCF Margin
GT Biopharma, Inc. FCF Margin History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-17251.8%
FY2016
5-year range
-17251.8% / -120.1%
FY2012-FY2016
Trend
-499.6%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin changed -500% YoY in FY2016, a notable deviation from the 4-year average annual change of -661%.
Based on SEC 10-K filings.
-17251.8% in FY2016 with a 3-year CAGR of -16962.7%.
Declined from -120.1% to -17251.8% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -16962.7pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2016, fcf margin decreased 499.6% year-over-year.
- Peak fcf margin was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | - | - |
| FY2017 | - | - |
| FY2016 | -17251.8% | -499.6% |
| FY2015 | -2877.0% | -2295.3% |
| FY2014 | -120.1% | +58.5% |
| FY2013 | -289.2% | +92.2% |
| FY2012 | -3703.8% | - |
| FY2011 | - | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026